XML 79 R69.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Narrative) (Details)
€ in Millions
6 Months Ended
Jul. 04, 2021
USD ($)
Jul. 05, 2020
USD ($)
Jul. 04, 2021
EUR (€)
Apr. 04, 2021
USD ($)
Mar. 08, 2021
USD ($)
Jan. 03, 2021
USD ($)
Jan. 03, 2021
EUR (€)
Apr. 05, 2020
USD ($)
Dec. 29, 2019
USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $ 3,334,000 $ 13,726,000   $ 3,124,000   $ 2,953,000   $ 22,777,000 $ 35,481,000
Unamortized Debt Issuance Expense 19,459,000         12,540,000      
Debt Instrument, Unamortized Discount (5,412,000)         (5,765,000)      
Payments for acquisition related contingent consideration 0 $ (5,200,000)              
2.55 Percent Senior Unsecured Notes due in 2031 [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Unamortized Debt Issuance Expense 3,563,000                
Unsecured senior notes, face value         $ 400,000,000.0        
Debt Instrument, Unamortized Discount (136,000)       (100,000)        
3.625 Percent Senior Unsecured Notes due in 2051 [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Unamortized Debt Issuance Expense 4,545,000                
Unsecured senior notes, face value         400,000,000.0        
Debt Instrument, Unamortized Discount (4,000)       $ (4,000)        
Line of Credit, Maturing September 17, 2024 [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Revolving credit facility outstanding balance 125,000,000         158,595,000      
Unamortized Debt Issuance Expense 2,264,000         2,621,000      
Long-term Debt 122,736,000         155,974,000      
Debt Instrument, Unamortized Discount 0         0      
1.875 Percent Ten Year Senior Unsecured Notes [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Unamortized Debt Issuance Expense 2,531,000         2,782,000      
Debt Instrument, Unamortized Discount (2,904,000)         (3,253,000)      
0.6 Percent Senior Unsecured Notes due in April 2021 [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Unamortized Debt Issuance Expense           229,000      
Debt Instrument, Unamortized Discount           (16,000)      
3.3 Percent Ten Year Senior Unsecured Notes due in Sept 2029 [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Unamortized Debt Issuance Expense 6,556,000         6,908,000      
Debt Instrument, Unamortized Discount (2,368,000)         (2,496,000)      
Senior Unsecured Notes [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Unsecured senior notes, fair value 2,411,600,000         1,984,300,000      
Other Debt Facilities, excluding the senior revolving credit facility [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Long-term Debt, Percentage Bearing Fixed Interest, Amount | €     € 10.7            
DNA Labs & Biosense [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $ 7,200,000                
Business Combination, Contingent Consideration Arrangements, Description Contingent consideration is measured at fair value at the acquisition date, based on the probability that revenue thresholds or product development milestones will be achieved during the earnout period, with changes in the fair value after the acquisition date affecting earnings to the extent it is to be settled in cash.                
Business Combination, Contingent Consideration Arrangements, Maximum Period 1 year 6 months                
Business Combination, Contingent Consideration Arrangements, Weighted Average Period 9 months 18 days                
Significant Other Observable Inputs (Level 2) [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Long-term Debt $ 2,348,523,000         1,609,701,000      
Significant Other Observable Inputs (Level 2) [Member] | 2.55 Percent Senior Unsecured Notes due in 2031 [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Long-term Debt 396,301,000                
Significant Other Observable Inputs (Level 2) [Member] | 3.625 Percent Senior Unsecured Notes due in 2051 [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Long-term Debt 395,451,000                
Significant Other Observable Inputs (Level 2) [Member] | 1.875 Percent Ten Year Senior Unsecured Notes [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Long-term Debt 586,865,000         604,715,000      
Significant Other Observable Inputs (Level 2) [Member] | 3.3 Percent Ten Year Senior Unsecured Notes due in Sept 2029 [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Long-term Debt 841,076,000         840,596,000      
Significant Other Observable Inputs (Level 2) [Member] | Senior Unsecured Notes [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Long-term Debt $ 2,219,700,000         $ 1,811,500,000      
Significant Other Observable Inputs (Level 2) [Member] | Other Debt Facilities, including the senior revolving credit facility [Member]                  
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]                  
Other Long-term Debt | €     € 133.5       € 179.1